Advertisement

Glycoconjugate Journal

, Volume 8, Issue 5, pp 424–433 | Cite as

Blood group type glycosphingolipids of human kidneys. Structural characterization of extended globo-series compounds

  • Jan Holgersson
  • Per-Åke Jovall
  • Bo E. Samuelsson
  • Michael E. Breimer
Papers

Abstract

Blood group type glycosphingolipids present in kidneys of blood group A and B human individuals have been isolated and structurally characterized by mass spectrometry, proton NMR spectroscopy, degradation studies and by their reactivity with various monoclonal antibodies andEscherichia coli bacteria. The two major complex glycolipids present in the blood group A and B kidneys were globopentaosylceramide (IV3Galβ-Gb4Cer) and the X pentaglycosylceramide (III3Fucα-nLc4Cer). The major blood group A glycolipid in the blood group A kidneys was based on the type 4 chain (globo-series). There were also small amounts of the type 2 chain and trace amounts of the type 1 and type 3 chain based A glycolipids. In addition, the blood group H type 4 chain structure was present together with Lea and Leb compounds. In the blood group B kidneys, the major B glycolipids were monofucosylated hexa- and octaglycosylceramides, where the former were based on the type 2 carbohydrate chain. The blood group B type 4 chain heptaglycosylceramide was found to be a minor component making up only about 1% of the total blood group B structures.

Keywords

glycolipids blood groups human kidney mass spectrometry proton NMR spectroscopy 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Makita A (1964)J Biochem (Tokyo) 55:269–76.Google Scholar
  2. 2.
    Mårtensson E (1966)Biochim Biophys Acta 116:296–308.Google Scholar
  3. 3.
    Mårtensson E (1969) InProgress in the Chemistry of Fats and Other Lipids (Holman RT, ed.) Vol X, part 4, pp 367–407. Oxford: Pergamon Press.Google Scholar
  4. 4.
    Rauvala H (1976)FEBS Lett 62:161–4.Google Scholar
  5. 5.
    Rauvala H (1976)J Biol Chem 251:7517–20.Google Scholar
  6. 6.
    Breimer ME, Samuelsson BE (1986)Transplant 42:88–91.Google Scholar
  7. 7.
    Rydberg L, Breimer ME, Samuelsson BE, Brynger H (1987)Transplant Proc 19:4528–37.Google Scholar
  8. 8.
    Breimer ME, Jovall PÅ (1985)FEBS Lett 179:165–72.Google Scholar
  9. 9.
    Breimer ME (1985)Glycoconjugate J 2:375–85.Google Scholar
  10. 10.
    Karlsson K-A (1987)Methods Enzymol 138:212–20.Google Scholar
  11. 11.
    Breimer M, Hansson GC, Karlsson K-A, Leffler H (1982)J Biol Chem 257:906–16.Google Scholar
  12. 12.
    Breimer ME, Hansson GC, Larson G (1983) InProc 7th Int Symp Glycoconjugates (Chester MA, Heinegård D, Lundblad A, Svensson S, eds) pp 421–2. Lund, Sweden: Secretariat.Google Scholar
  13. 13.
    Magnani JC, Smith DF, Ginsburg V (1981)Anal Biochem 109:399–402.Google Scholar
  14. 14.
    Hansson GC, Karlsson K-A, Larson G, McKibbin JM, Blaszczyk M, Herlyn M, Steplewski Z, Koprowski H (1983)J Biol Chem 258:4091–7.Google Scholar
  15. 15.
    Falk K-E, Karlsson K-A, Samuelsson BE (1979)Arch Biochem Biophys 192:191–202.Google Scholar
  16. 16.
    Ciucanu I, Kerek F (1984)Carbohydr Res 131:209–17.Google Scholar
  17. 17.
    Larson G, Karlsson H, Hansson GC, Pimlott W (1987)Carbohydr Res 161:281–90.Google Scholar
  18. 18.
    Karlsson K-A (1974)Biochemistry 13:3643–7.Google Scholar
  19. 19.
    Breimer ME, Hansson GC, Karlsson K-A, Leffler H, Pimlott W, Samuelsson BE (1979)Biomed Mass Spectrom 6:231–41.Google Scholar
  20. 20.
    Breimer ME, Hansson GC, Karlsson K-A, Larson G, Leffler H, Pascher I, Pimlott W, Samuelsson BE (1980)Adv Mass Spectrom 8:1097–108.Google Scholar
  21. 21.
    Stellner K, Saito H, Hakomori S (1973)Arch Biochem Biophys 155:464–72.Google Scholar
  22. 22.
    Breimer ME, Karlsson K-A, Samuelsson BE (1981)J Biol Chem 256:3810–6.Google Scholar
  23. 23.
    Le Pendu J, Lambert F, Samuelsson BE, Breimer ME, Seitz RC, Urdanitz MP, Suesa N, Murray R, Francois A, Poschmann A, Viñas J, Oriol R (1986)Glycoconjugate J 3:255–71.Google Scholar
  24. 24.
    Abe K, Levery SB, Hakomori S (1984)J Immunol 132:1951–4.Google Scholar
  25. 25.
    Bock K, Breimer ME, Brignole A, Hansson GC, Karlsson K-A, Larson G, Leffler H, Samuelsson BE, Strömberg N, Svanborg Edén C, Thurin J (1985)J Biol Chem 260:8545–51.Google Scholar
  26. 26.
    Rydberg L, Breimer ME, Samuelsson BE (1988)Transfusion 28:483–8.Google Scholar
  27. 27.
    Dabrowski J, Hanfland P, Egge H, Dabrowski U (1981)Arch Biochem Biophys 210:405–11.Google Scholar
  28. 28.
    Kannagi R, Levery SB, Ishigami F, Hakomori S, Shevinsky LH, Knowles BB, Soler D (1983)J Biol Chem 258:8934–42.Google Scholar
  29. 29.
    Dabrowski J, Hanfland P, Egge H (1980)Biochemistry 19:5652–8.Google Scholar
  30. 30.
    Karlsson K-A, Larson G (1981)J Biol Chem 256:3512–24.Google Scholar
  31. 31.
    Breimer ME, Karlsson K-A, Samuelsson BE (1982)J Biol Chem 257:1079–85.Google Scholar
  32. 32.
    Kannagi R, Levery S, Hakomori S (1984)FEBS Lett 175:397–401.Google Scholar
  33. 33.
    Karlsson K-A (1977)Progr Chem Fats Lipids 16:207–30.Google Scholar
  34. 34.
    Breimer ME, Karlsson H, Karlsson K-A, Nilsson K, Samuelsson BE, Strömberg N (1988)Carbohydr Res 178:111–20.Google Scholar
  35. 35.
    Levery SB, Nudelman ED, Andersen NH, Hakomori S (1986)Carbohydr Res 151:311–28.Google Scholar
  36. 36.
    Clausen H, Watanabe K, Kannagi R, Levery SB, Nudelman E, Arao-Tomono Y, Hakomori S (1984)Biochem Biophys Res Commun 124:523–9.Google Scholar
  37. 37.
    Clausen H, Levery SB, Nudelman E, Tsuchiya S, Hakomori S (1985)Proc Natl Acad Sci USA 82:1199–203.Google Scholar
  38. 38.
    Clausen H, Levery SB, Nudelman E, Baldwin M, Hakomori S (1986)Biochemistry 25:7075–85.Google Scholar
  39. 39.
    Rydberg L, Breimer ME, Brynger H, Samuelsson BE (1990)Transplant 49:954–60.Google Scholar
  40. 40.
    Hakomori S, Wang S-M, Young WW (1977)Proc Natl Acad Sci USA 74:3023–7.Google Scholar
  41. 41.
    Hakomori S, Young WW (1983) InSphingolipid Biochemistry (Kanfer JN, Hakomori S, eds) pp 381–436. New York: Plenum.Google Scholar
  42. 42.
    Schwarting GA, Carroll PG, DeWolf WC (1983)Biochem Biophys Res Commun 112:935–40.Google Scholar
  43. 43.
    Nagai K, Roberts DD, Toida T, Matsumoto H, Kushi Y, Handa S, Ishizuka I (1989)J Biol Chem 264:16229–37.Google Scholar
  44. 44.
    Leffler H, Svanborg-Edén C (1980)FEMS Microbiol Lett 8:127–34.Google Scholar
  45. 45.
    Källenius G, Möllby R, Svensson SB, Winberg J, Lundblad A, Svensson S, Cedergren B (1980)FEMS Microbiol Lett 7:297–302.Google Scholar
  46. 46.
    Senior D, Baker N, Cedergren B, Falk P, Larson G, Lindstedt R, Svanborg-Edén C (1988)FEBS Lett 237:123–7.Google Scholar
  47. 47.
    Lindstedt R, Baker N, Falk P, Hull R, Hull S, Karr J, Leffler H, Svanborg-Edén C, Larson G (1989)Infect Immunity 57:3389–94.Google Scholar
  48. 48.
    Breimer ME, Hansson G, Leffler H (1985)J Biochem (Tokyo) 98:1169–80.Google Scholar
  49. 49.
    Clausen H, Hakomori S (1989)Vox Sang 56:1–20.Google Scholar

Copyright information

© Chapman & Hall 1991

Authors and Affiliations

  • Jan Holgersson
    • 1
  • Per-Åke Jovall
    • 1
  • Bo E. Samuelsson
    • 1
  • Michael E. Breimer
    • 2
  1. 1.Department of Medical BiochemistryUniversity of GöteborgGöteborgSweden
  2. 2.Department of SurgeryUniversity of Göteborg, Sahlgren's HospitalGöteborgSweden

Personalised recommendations